Management of EKG Changes After Coronary Artery Bypass Grafting (CABG)
Continuous electrocardiogram (ECG) monitoring should be performed for at least 48 hours in all patients after CABG surgery to detect arrhythmias and ischemic changes. 1
Types of ECG Changes Post-CABG
Arrhythmias
- Atrial Fibrillation: Most common arrhythmia (occurs in 27% of patients), typically occurring 2-4 days post-surgery 1, 2
- Ventricular Arrhythmias: Less common but potentially life-threatening
- Conduction Abnormalities: Bundle branch blocks may develop and are associated with increased risk of atrial fibrillation 2
ST-Segment Changes
- ST-segment depression: May indicate subendocardial ischemia
- ST-segment elevation: May represent transmural ischemia, graft occlusion, or non-specific post-surgical changes 3
- T-wave inversions: May indicate ischemia or be non-specific
Management Algorithm for ECG Changes Post-CABG
1. Immediate Assessment of Significant ECG Changes
- For ST-segment elevation ≥0.2 mV or ST-segment depression ≥0.1 mV lasting >1 minute 4:
- Obtain 12-lead ECG to confirm changes
- Assess vital signs and hemodynamic stability
- Review recent cardiac biomarkers (troponin, CK-MB)
- Evaluate for symptoms (chest pain, dyspnea)
2. Management Based on Hemodynamic Status
For Hemodynamically Stable Patients:
- Continue close monitoring
- Obtain serial cardiac biomarkers (troponin, CK-MB)
- Consider echocardiography to assess wall motion abnormalities
- If changes persist with rising biomarkers, consider coronary angiography
For Hemodynamically Unstable Patients:
- Immediate notification of cardiac surgery team
- Initiate resuscitation measures if needed
- Consider emergency coronary angiography with possible intervention
- Prepare for possible return to operating room if graft failure is suspected
3. Management of Specific ECG Changes
For New ST-Segment Elevation:
- High suspicion for graft occlusion - ST elevation post-CABG can represent significant pathology requiring prompt investigation 3
- Consider immediate coronary angiography if:
- Changes persist >30 minutes
- Associated with hemodynamic instability
- Accompanied by rising cardiac biomarkers
For ST-Segment Depression:
- Evaluate for potential causes:
- Subendocardial ischemia
- Incomplete revascularization
- Graft spasm or thrombosis
- Optimize hemodynamics (maintain adequate blood pressure, avoid tachycardia)
- Consider coronary angiography if changes persist with clinical deterioration
For Arrhythmias:
- Atrial Fibrillation:
- Rate control with beta-blockers (preferred) 2
- Consider amiodarone for refractory cases
- Anticoagulation if persistent >48 hours
- Ventricular Arrhythmias:
- Correct electrolyte abnormalities
- Consider amiodarone for sustained ventricular tachycardia
- Evaluate for underlying ischemia
Monitoring Recommendations
- Duration: Continuous ECG monitoring for at least 48 hours post-CABG 1
- Lead Selection: Optimal two-lead set is V5 and III (superior to commonly used V5 and II) 5
- ST-Segment Analysis: Automated ST-segment monitoring has 100% negative predictive value for adverse cardiac outcomes 4
Important Considerations and Pitfalls
Timing of Events: Most significant ECG changes occur within the first 8 hours after release of aortic cross-clamp 6
Biomarker Peaks: CK-MB typically peaks by 16 hours after aortic cross-clamp release 6
Non-ischemic Causes of ST Changes: Consider:
- Pericarditis
- Electrolyte abnormalities
- Hypothermia
- Effects of cardioplegia
- Conduction abnormalities
Risk Factors for Post-CABG Ischemia:
- Prolonged aortic cross-clamp time
- Prolonged cardiopulmonary bypass time
- Intraoperative hypotension (SBP <90 mmHg) after cardiopulmonary bypass 6
Prevention Strategies
- Beta-blockers may reduce the incidence of atrial fibrillation (14.8% vs 27% in controls) 2
- Maintain adequate hemodynamics (target SBP 90-140 mmHg) 7
- Optimize fluid management with careful monitoring of intake and output 7
- Maintain hematocrit >24% or hemoglobin >8 g/dL 7
By implementing systematic monitoring and prompt management of ECG changes after CABG, clinicians can significantly reduce morbidity and mortality associated with post-operative ischemic events and arrhythmias.